[HTML][HTML] Transmissibility of COVID-19 depends on the viral load around onset in adult and symptomatic patients
…, Y Fukui, Y Yoshida, M Kimura, H Yamada, I Sakamaki… - PloS one, 2020 - journals.plos.org
Objective To investigate the relationship between viral load and secondary transmission in
novel coronavirus disease 2019 (COVID-19). Methods Epidemiological and clinical data …
novel coronavirus disease 2019 (COVID-19). Methods Epidemiological and clinical data …
Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice
H Qin, B Lerman, I Sakamaki, G Wei, SC Cha… - Nature medicine, 2014 - nature.com
Immune evasion is an emerging hallmark of cancer progression. However, functional
studies to understand the role of myeloid-derived suppressor cells (MDSCs) in the tumor …
studies to understand the role of myeloid-derived suppressor cells (MDSCs) in the tumor …
The effect of combined IL10 siRNA and CpG ODN as pathogen-mimicking microparticles on Th1/Th2 cytokine balance in dendritic cells and protective immunity …
P Pradhan, H Qin, JA Leleux, D Gwak, I Sakamaki… - Biomaterials, 2014 - Elsevier
Success of an immunotherapy for cancer often depends on the critical balance of T helper 1
(Th1) and T helper 2 (Th2) responses driven by antigen presenting cells, specifically …
(Th1) and T helper 2 (Th2) responses driven by antigen presenting cells, specifically …
SARS‐CoV‐2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID‐19
…, M Kimura, H Yamada, I Sakamaki… - Journal of Medical …, 2022 - Wiley Online Library
This study aimed to determine the frequency of SARS‐CoV‐2 RNA in serum and its
association with the clinical severity of COVID‐19. This retrospective cohort study performed at …
association with the clinical severity of COVID‐19. This retrospective cohort study performed at …
[HTML][HTML] Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein
…, H Kawasuji, A Ueno, Y Miyajima, Y Fukui, I Sakamaki… - Virology journal, 2021 - Springer
Background SARS-CoV-2 is a novel coronavirus that emerged in 2019 and is now
classified in the genus Coronavirus with closely related SARS-CoV. SARS-CoV-2 is highly …
classified in the genus Coronavirus with closely related SARS-CoV. SARS-CoV-2 is highly …
Lenalidomide enhances the protective effect of a therapeutic vaccine and reverses immune suppression in mice bearing established lymphomas
I Sakamaki, LW Kwak, SC Cha, Q Yi, B Lerman, J Chen… - Leukemia, 2014 - nature.com
Immunomodulatory drugs (IMiDs) are effective therapeutic agents with direct inhibitory effects
on malignant B-and plasma-cells and immunomodulatory effects on the T-cell activation. …
on malignant B-and plasma-cells and immunomodulatory effects on the T-cell activation. …
[HTML][HTML] Proposal of initial and maintenance dosing regimens with linezolid for renal impairment patients
…, A Ueno, Y Miyajima, K Kawago, I Sakamaki… - BMC Pharmacology and …, 2021 - Springer
Background Linezolid is administered as a fixed dose to all patients despite evidence of
overexposure and thrombocytopenia in renal impairment. The aims of this study were to …
overexposure and thrombocytopenia in renal impairment. The aims of this study were to …
Daptomycin-induced eosinophilic pneumonia and a review of the published literature
…, K Kawago, K Tokui, R Hayashi, I Sakamaki… - Internal …, 2018 - jstage.jst.go.jp
A 53-year-old man was admitted to the hospital with a diagnosis of cellulitis and osteomyelitis.
Twentyfour days after the initiation of daptomycin and sulbactam/ampicillin, he developed …
Twentyfour days after the initiation of daptomycin and sulbactam/ampicillin, he developed …
[HTML][HTML] Delayed neutralizing antibody response in the acute phase correlates with severe progression of COVID-19
…, Y Miyajima, K Kawago, Y Fukui, I Sakamaki… - Scientific Reports, 2021 - nature.com
Adaptive immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
dynamics remain largely unknown. The neutralizing antibody (NAb) levels in patients with …
dynamics remain largely unknown. The neutralizing antibody (NAb) levels in patients with …
Mycobacterium bovis-induced aneurysm after intravesical bacillus calmette-guérin therapy: a case study and literature review
…, J Isobe, J Kanatani, Y Kawagishi, I Sakamaki… - Internal …, 2018 - jstage.jst.go.jp
Mycobacterium bovis infection after intravesical Bacillus Calmette-Guérin (BCG) therapy is
rare. A 65-year-old Japanese man with history of bladder cancer and intravesical BCG …
rare. A 65-year-old Japanese man with history of bladder cancer and intravesical BCG …